SCHEMBL5865631

SCHEMBL5865631

FC(F)(F)c1ccc(C(=C(Cl)Cl)c2ccc(Br)cc2)cc1Br

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.53
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KIF11 P52732 1/20 0.36
MAPT P10636 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
XBP1 P17861 1/20 0.35
PTPN7 P35236 1/20 0.35
DUSP3 P51452 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
NPC1 O15118 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
KDM1A O60341 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865588 0.89 CYP3A4 (0.53) NOTUMMEN1KMT2ACYP3A4TSHR
SCHEMBL5865578 0.89 MAPT (0.46) NOTUMMEN1KMT2ACYP3A4TSHR
SCHEMBL5865501 0.86 CYP3A4 (0.40) NOTUMMEN1KMT2ACYP3A4TSHR
SCHEMBL5865640 0.83 NPFFR2 (0.44) NOTUMMEN1KMT2ACYP3A4TSHR
SCHEMBL17110475 0.80 NOTUM (0.63) NOTUMMEN1KMT2AKIF11MAPT
SCHEMBL5865199 0.77 CYP3A4 (0.55) NOTUMMEN1KMT2ACYP3A4TSHR
SCHEMBL9494805 0.76 TSHR (0.59) MEN1KMT2ACYP3A4TSHRMAPK1
SCHEMBL6575819 0.74 MEN1 (0.37) MEN1KMT2ACYP3A4TSHRMAPK1
SCHEMBL29625081 0.74 NOTUM (0.65) NOTUMMEN1KMT2ATSHRL3MBTL1
SCHEMBL1811724 0.74 NOTUM (0.65) NOTUMMEN1KMT2ATSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091248-B2 Treatment of adrenocortical hypersecretion and tumor growth BRANDT INGVAR 2006-08-15 US disclosed
US-20040242705-A1 Novel treatment of adrenocortical hypersecretion and tumour growth BRANDT INGVAR (SE) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242705-A1 Novel treatment of adrenocortical hypersecretion and tumour growth NR3C2, NR5A1, NR3C1 NOTUM 1335/4885MEN1 899/4885KMT2A 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.